Pro CLB Global approved the allotment of 1,09,20,255 convertible warrants to 130 non-promoter investors on September 16, 2026. The preferential issue was priced at ₹31.96 per warrant, with an initial collection of ₹7.99 per warrant representing 25% of the total consideration.

The Board of Directors sanctioned the allotment during a meeting held on September 16, 2026, from 5:00 pm to 5:30 pm. The issuance complies with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018.

Allotment Details

The warrants entitle holders to subscribe to one equity share per warrant upon payment of the remaining 75% of the issue price. Holders must exercise this right within 18 months from the date of allotment. Failure to exercise the warrants within this period will result in their lapse, and the amounts paid will be forfeited by the company.

Ten applicants were not allotted warrants due to non-receipt of the required 25% upfront payment. These include Chirayu Aggarwal, Geeta Sanjay Arora, and Siroya Enterprise.

Key Investors

The allotment was distributed among a broad base of retail and high-net-worth individuals, along with a few corporate entities. Mideast Healthcare Pvt Ltd received the largest single allotment of 700,000 warrants. Rajnikant Chandulal Shukla HUF was allotted 650,000 warrants, followed by Neeta Mandevia with 531,915 warrants.

What the Numbers Show

The wide dispersion of allottees, with 130 distinct recipients and no single investor holding more than 4.37% of the post-allotment stake, indicates a strategy to broaden the shareholder base rather than consolidate control. The inclusion of multiple HUFs and individual family members suggests participation from the company's existing promoter or management circle, structured as non-promoter investments.

Pro CLB Global Limited has scheduled its 32nd annual general meeting for Wednesday, September 30, 2026. The meeting will be held via video conferencing to transact ordinary and special business items.

The company disclosed the notice on September 5, 2026, in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Members whose email IDs are registered as of September 4, 2026, have received the notice electronically.

Agenda Items

The AGM will address several key corporate governance matters:

• Adoption of the audited financial statements for the financial year ended March 31, 2026.
• Reappointment of Mr. Het Kalpeshkumar Shah as a Non-Executive Director, who retires by rotation.
• Appointment of M/s. Shweta Jain & Co LLP as Statutory Auditors for five years, until the conclusion of the 37th AGM.
• Regularization of Mr. Satish Papnai as an Independent Director through a special resolution.

Voting Process

The company has engaged CDSL to facilitate e-voting for its members. The e-voting period begins on Sunday, September 27, 2026, at 9:00 am and concludes on Tuesday, September 29, 2026, at 5:00 pm. Communication of assent or dissent will occur exclusively through this platform.

What the Numbers Show

This filing is a procedural disclosure regarding corporate governance and does not contain new financial performance data. The appointment of auditors for a five-year term aligns with standard regulatory practices under the Companies Act, 2013.